[Antibodies to the plasma membranes of thyrocytes in patients with diffuse toxic goiter during treatment with mercazole].
Antibodies to thyroid cell membranes (ATCM) were studied in sera from 49 patients with diffuse toxic goiter (DTG) using dot-immunobinding prior to treatment with mercazolyl and 1, 4, 12 and 24 mos. later. Among the DTG patients ATMC before treatment were detected in 75.5%; 4 mos. after the start of mercazolyl therapy ATCM were detected in 49% of the patients. Among patients in a long-term remission after mercazolyl therapy ATCM were detected in 37.5% pointing out to immunologic disturbance in these patients.